Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.12.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allergan plc - AGN (PR Newswire)
19.12.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allergan plc - AGN (PR Newswire)
19.12.18	Allergan Suspends Sales, Withdraws Supply Of Textured Breast Implants In Europe (RTTNews)
20.11.18	Allergan: FDA To Review SNDA Filing For AVYCAZ - Quick Facts (RTTNews)
30.10.18	Allergan Lifts 2018 Adj. Profit And Net Revenue Outlook (RTTNews)
30.10.18	Allergan Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
16.10.18	FDA Oks Medicines360' SNDA For LILETTA 52Mg To Prevent Pregnancy For Up To 5-yrs (RTTNews)
05.10.18	Allergan Launches Study Approach For Clinical Research Programs In IBD (RTTNews)
04.10.18	Allergan Obtains FDA Clearance To Treat Area Below Jawline With CoolSculpting (RTTNews)
28.09.18	Biotech Stocks Facing FDA Decision In October (RTTNews)
17.09.18	Botox Effect Lasts Longer At Higher Doses, TEVA Gets FDA Nod, KNSA On Watch (RTTNews)
14.09.18	Allergan To Buy Bonti For Upfront Payment Of $195 Mln & Addl Milestone Payments (RTTNews)
22.08.18	FDA Snubs Allergan, GNMX Gets Attention, Another Month, Another Suitor For CBPO (RTTNews)
22.08.18	Allergan Gets CRL From FDA For Ulipristal Acetate NDA (RTTNews)
26.07.18	Allergan Updates 2018 Outlook; Board Authorizes $2.0 Bln Share Buyback (RTTNews)
26.07.18	Allergan Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
14.06.18	Allergan Says Thomas Freyman To Join Board; Patrick O'Sullivan To Retire (RTTNews)
14.06.18	Allergan Continues Active Board Refreshment Process (PR Newswire)
13.06.18	Allergan Reports Positive Topline Phase 3 Clinical Data For Bimatoprost SR (RTTNews)
13.06.18	Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension (PR Newswire)
11.06.18	Allergan: Atogepant Shows Robust Efficacy, Safety In Phase 2b/3 Trial (RTTNews)
11.06.18	Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial (PR Newswire)
06.06.18	Juin est le mois national de la sensibilisation à la migraine et aux maux de tête (PR Newswire)
06.06.18	June is National Migraine and Headache Awareness Month (PR Newswire)
05.06.18	Allergan Responds to Public Shareholder Letter (PR Newswire)
05.06.18	Allergan Teams Up with a Host of Celebrities to Encourage Alzheimer's Patients and their Caregivers to Hold on to Hope (PR Newswire)
01.06.18	Atlantic Power Corporation and Atlantic Power Preferred Equity Ltd. Announce Quarterly Dividends on the Cumulative Redeemable Preferred Shares, Series 1, Cumulative Rate Reset Preferred Shares,... (PR Newswire)
30.05.18	Lincoln Tech Expands Partnership with Bridgestone Retail Operations to Provide Nationwide Workforce Development (PR Newswire)
29.05.18	Allergan Voluntary Recalls One Lot Of Taytulla Softgel Capsules In U.S. (RTTNews)
22.05.18	Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research Collaboration (PR Newswire)
21.05.18	Phreesia Selected as one of Modern Healthcare's "Best Places to Work in Healthcare" for the Third Year in a Row (PR Newswire)
17.05.18	Chubb Shareholders Approve 25th Consecutive Annual Dividend Increase; Board Declares Record Date for First Dividend Installment; All Other Shareholder Proposals Approved (PR Newswire)
16.05.18	Allergan to Present at the Bernstein Strategic Decisions Conference (PR Newswire)
09.05.18	In The Spotlight: Evolus (RTTNews)
07.05.18	Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference (PR Newswire)
04.05.18	The Safariland Group Appoints Blaine Browers as Chief Financial Officer (PR Newswire)
04.05.18	The Safariland Group Appoints Blaine Browers as Chief Financial Officer (PR Newswire)
03.05.18	John Davidson Elected to Allergan Board of Directors (PR Newswire)
03.05.18	Allergan Declares Second Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share (PR Newswire)
03.05.18	Los Angeles and Atlanta are Home to the Nation's Most Popular Neighborhoods (PR Newswire)
02.05.18	Ameritech Financial on Entrepreneurship and Student Loans (PR Newswire)
02.05.18	Allergan to Present Data from a Robust Mental Health Clinical Program at the American Psychiatric Association (APA) 2018 Annual Meeting (PR Newswire)
02.05.18	Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit (PR Newswire)
01.05.18	Allergan to Present at the Deutsche Bank 43rd Annual Health Care Conference (PR Newswire)
01.05.18	Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action (PR Newswire)
01.05.18	NTN Buzztime activist sends demand letter to the company's Board of Directors to inspect NTN's books & records for a list of the company's shareholders (PR Newswire)
30.04.18	Allergan Boosts 2018 Outlook As Q1 Results Top Estimates - Quick Facts (RTTNews)
30.04.18	Allergan Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
30.04.18	Allergan Reports 3% Increase in First Quarter 2018 GAAP Net Revenues to $3.7 Billion (PR Newswire)
27.04.18	Allergan Announces Second Positive Phase 3 Trial For Ubrogepant (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Allergan plc

Aktien Top/Flop

Allergan Peer Group Nachrichten

Meistgelesene Nachrichten